Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials

BACKGROUND: The aim of the study was to estimate the minimally important difference (MID) for interpreting group-level change over time, both within a group and between groups, for the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gamper, Eva M., Musoro, Jammbe Z., Coens, Corneel, Stelmes, Jean-Jacques, Falato, Claudette, Groenvold, Mogens, Velikova, Galina, Cocks, Kim, Flechtner, Hans-Henning, King, Madeleine T., Bottomley, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496068/
https://www.ncbi.nlm.nih.gov/pubmed/34620124
http://dx.doi.org/10.1186/s12885-021-08609-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496068/
https://www.ncbi.nlm.nih.gov/pubmed/34620124
http://dx.doi.org/10.1186/s12885-021-08609-7

Ejemplares similares